Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery

Published

on

Reading Time: 2 minutes

PARIS–(BUSINESS WIRE)–Iktos, a company specializing in Artificial Intelligence (AI)
technologies applied to new drug design, announced today the initiation
of a collaboration agreement with Janssen Pharmaceutica NV. As part of
the collaboration, Iktos virtual drug design technology will be
implemented and applied to several Janssen small molecule drug discovery
projects. Iktos will collaborate with Janssen to develop new
applications, leveraging Iktos’ proprietary know-how in deep generative
models applied to chemistry and Janssen expertise in AI-enabled
prediction of small molecule activities.

Building on deep generative models, Iktos is developing a proprietary
and innovative technology for in silico drug design which has the
potential to enable vast improvements in drug discovery workflows, based
on its unique capacity to explore chemical space with speed and
efficiency, thus enabling identification of molecules that meet the
desired criteria in a given research project.

“We are thrilled to be able to announce a strategic collaboration with
Janssen, one of the largest pharma companies in the world, and highly
respected for the quality of their science and their visionary
perspective regarding the use of big data and machine learning to
progress pharma R&D efficiency,” commented Yann Gaston-Mathé, CEO of
Iktos. “It is a major recognition for Iktos to be selected by Janssen as
a partner for implementation and development of generative modeling
technology for new drug design. Iktos has been a pioneer in the
application of generative models for drug discovery and is emerging as a
world leader in a technology that has the potential to disrupt the way
new therapeutics are designed.”

Iktos has recently announced collaborations with several
biopharmaceutical companies where Iktos AI technology is used to
accelerate the design of promising compounds, and has published, at the
EFMC 2018 meeting, an experimental validation of the technology in a
real-life drug discovery project. Iktos is planning to release its SaaS
software, Makya™, as a beta version available for testing by customers,
by mid-2019.

About Iktos

Incorporated in October 2016, Iktos is a French start-up company
specializing in the development of artificial intelligence solutions
applied to chemical research, more specifically medicinal chemistry and
new drug design. Iktos is developing a proprietary and innovative
solution based on deep learning generative models, which enables the use
of existing data to design molecules that are optimized in silico
to meet the success criteria of a small molecule discovery project. The
use of Iktos technology enables major productivity gains in upstream
pharmaceutical R&D. Iktos offers its technology to its customers both as
professional services and as a SaaS software platform, Makya™.
More
information on: www.iktos.ai

Contacts

Yann Gaston-Mathé (CEO)
[email protected]
+33
6 30 07 99 26


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III

Published

on

Continue Reading

Humboldt

Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace

Published

on

humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace

Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia

SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.

The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.

Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.

“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”

Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”

About Humboldt Seed Company

Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.

For more information visit https://humboldtseedcompany.com/.

About Apollo Green

Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics. 

For more information visit https://apollogreen.com/.

Media contact
Jaana Prall
[email protected] 

Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html

Continue Reading

Cannabis

Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania